Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook

A Journal and Its Editorial Board

A scholarly journal thrives on its peer review process whereby manuscripts submitted to the journal are reviewed for originality, novelty and contribution to the existing literature, scientific or otherwise. This is true for the PDA JPST. In this context, the editorial board, by its very definition, provides the expertise and counsel, assesses submitted articles for their depth and validates the quality of research by their review. Membership in a journal's editorial board provides networking opportunities, an opportunity to sharpen one's own writing skills and an opportunity to learn about cutting-edge research. I am very fortunate to be able to call upon a very capable advisory board.

Prior to the 2022 PDA/FDA Joint Regulatory Conference in Washington, DC, the JPST Editorial Board met on Sunday, 11 September. A hybrid meeting, some of us met at PDA headquarters in Bethesda, MD, while others joined in remotely. The technology worked. We had a lively discussion around different aspects of the PDA JPST submission process and the time from submission to publication of an accepted manuscript. There was a unanimous agreement on reducing the time it takes to review a given manuscript. Several of the board members offered to solicit research articles and recommend future reviewers from their professional network. I look forward to it already.

Click here for Dr. Gupta's complete Sept-Oct Editorial. 

Accepted Articles

  • You have access
    Design, Development and Validation of a Culture-Independent Nucleic Acid Diagnostics Method for the Rapid Detection and Quantification of the Burkholderia cepacia Complex in Water with an Equivalence to ISO/TS 12869:2019
    Huong Thu Duong, Shannon Fullbrook, Kate Reddington, Elizabeth Minogue and Thomas Barry
    PDA Journal of Pharmaceutical Science and Technology February 2023, pdajpst.2021.012728; DOI: https://doi.org/10.5731/pdajpst.2021.012728
  • You have access
    Rapid Sterility Test Systems in the Pharmaceutical Industry: Applying a Structured Approach to their Evaluation, Validation and Global Implementation
    Sven Deutschmann, Mousumi Paul, Marja Claassen-Willemse, Jonas van den Berg, Pieta IJzerman-Boon, Viviane Grunert da Fonseca, Ellen Brunbech, Lynn Johnson, Chris Knutsen, Lucile Plourde, Joanny Salvas, Philip Villari, Lisa Wysocki and Margit Franz-Riethdorf
    PDA Journal of Pharmaceutical Science and Technology January 2023, pdajpst.2021.012672; DOI: https://doi.org/10.5731/pdajpst.2021.012672
  • You have access
    Development and Qualification of Visible Particle Load Analysis Methods for Injectable Drug Product Primary Packaging Components
    Robin Wagner, Peter Masatani, Dana Grace, Gianpiero Torraca, Stephanie Moore and David Semin
    PDA Journal of Pharmaceutical Science and Technology December 2022, pdajpst.2021.012710; DOI: https://doi.org/10.5731/pdajpst.2021.012710
  • You have access
    Single-Use System Integrity IV: A Holistic Approach Based on Compiled Scientific Study Data
    Marc Hogreve
    PDA Journal of Pharmaceutical Science and Technology December 2022, pdajpst.2022.012794; DOI: https://doi.org/10.5731/pdajpst.2022.012794
  • You have access
    Multisite Qualification of an Automated Incubator and Colony Counter for Environmental and Bioburden Applications in Pharmaceutical Microbiology
    Hans Joachim Anders, Daniel Mannle, William Carpenter, Wolfgang Eder, Ivana Heckel, Tobias Gotzen, Corinne Oechslin, Cedric Joosen, Maria Eugenia Giribets Parra, Jason Rose, Vaishali Shah and David L Jones
    PDA Journal of Pharmaceutical Science and Technology November 2022, pdajpst.2022.012742; DOI: https://doi.org/10.5731/pdajpst.2022.012742
  • You have access
    Flexible loading pattern approach in overkill steam sterilization based on the physical properties of steam and thermodynamics of sterilization
    Arnan Ben-David
    PDA Journal of Pharmaceutical Science and Technology October 2022, pdajpst.2021.012708; DOI: https://doi.org/10.5731/pdajpst.2021.012708
View more published ahead of print articles

Current Issue

PDA Journal of Pharmaceutical Science and Technology: 77 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 77, Issue 1
January/February 2023
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Sign up for Alerts

Featured Articles

  • Controls to Minimize Disruption of the Pharmaceutical Supply Chain During the COVID-19 Pandemic
    July 31, 2020
  • Evaluation of a Novel Prefilled Syringe Concept for Ophthalmic Applications: A Formative Human...
    February 01, 2022
  • Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable...
    October 05, 2020
  • Comparison of Limulus Amoebocyte Lysate and Recombinant Factor C Assays for Endotoxin...
    July 31, 2020
  • Physicochemical Excipient-Container Interactions in Prefilled Syringes and Their Impact on Syringe...
    August 03, 2021
  • Evaluating Nitrosamines from Elastomers in Pharmaceutical Primary Packaging
    April 01, 2022
  • My Last Issue as Editor-in-Chief
    April 01, 2022

PDA President Richard Johnson's 2022 Message

2021 was a challenging year for everyone, and PDA was not an exception. Last year at this time I shared the impact that the pandemic had on PDA in 2020. We were looking forward to a brighter 2021, and in some ways it was better. Vaccines for COVID were developed, proven, and released in record speed, and our community had a significant role in making that possible.

We also brought together industry, suppliers and regulators in a joint effort to address these challenges. Nonetheless, the pandemic continued throughout 2021 and into the present year. We have had positive signs, followed by resurgence of infections and the resulting societal and human impact. For PDA, it had the effect of making us postpone our return to in-person gatherings, and shift (again) to all-virtual. Of more importance has been the staggering human cost, that as of January 27, 2022, has resulted in over 5.5 million deaths, and more than 364 million cases worldwide. In addition to the terrible health impacts, the control measures that are continuing to be implemented have affected many more people’s livelihood and social activity.

Click here to read more.

 

  • Most Cited
  • Most Read
Loading
  • A New Integrated Modeling Approach with Case Studies for Gas Transmission of Container Closure Headspace
  • A Commentary on Several Study Design Considerations Pertaining to the Screening of Substances Extracted and/or Leached from Pharmaceutical Contact Materials
  • Low-Volume Aseptic Filling Using a Linear Peristaltic Pump
  • The Implications of Chromatographically Screening Medical Products for Organic Leachables Down to the Analytical Evaluation Threshold Adjusted for Response Factor Variation
More...

Back to top

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2023 PDA Journal of Pharmaceutical Science and Technology ISSN: 1079-7440

Powered by HighWire